HB 1207 Indiana House · 2020 Regular Session

Pharmacy matters.

Summary
Provides that a state employee plan, a health maintenance organization, an insurer, or a pharmacy benefits manager (health plan provider) may not require a pharmacy or pharmacist to collect a higher copayment for a prescription drug from a covered individual than the health plan provider allows the pharmacy or pharmacist to retain. Allows a pharmacist who meets certain requirements to dispense auto-injectable epinephrine by standing order to a person who: (1) has completed a course on auto-injectable epinephrine; and (2) is an individual in a position to assist an individual who is at risk of experiencing anaphylaxis. Allows a person to administer auto-injectable epinephrine to an individual who is experiencing anaphylaxis if certain conditions are met. Requires the state department of health (state department) to issue a statewide standing order authorizing the dispensing of auto-injectable epinephrine. Authorizes the state health commissioner to issue a statewide standing order authorizing the dispensing of auto-injectable epinephrine. Extends certain immunities to the state department, the state health commissioner, and certain designated public health authorities. Requires the state department to approve courses concerning the administration of auto-injectable epinephrine. Requires a person to have successfully completed the course to be immune from civil liability. Adds exceptions to the requirement that controlled substance prescriptions be in an electronic format. Provides that the board of pharmacy, in consultation with the medical licensing board, may adopt emergency rules. Adds advanced practice registered nurses and physician assistants to the list of out-of-state providers whose prescriptions a pharmacist has a duty to honor. Allows a prescription for a patient to be transferred electronically or by facsimile by a pharmacy to another pharmacy if the pharmacies do not share a common data base. Allows a licensed pharmacy technician to transfer the prescription. Allows a pharmacist to substitute a therapeutic alternative for epinephrine products for a patient and to prescribe sterile water for injection with a prescription drug. Allows a pharmacy technician to administer an influenza immunization to an individual under a drug order or prescription, subject to rules adopted by the board of pharmacy. Provides that aggregated information compiled from annual reports of pharmacy benefit managers to the insurance commissioner is not confidential except for information that would reveal a specific pharmacy benefit manager's proprietary information. Requires: (1) a state employee health plan; and (2) an insurer-provided health plan that complies with the federal Affordable Care Act; to establish a procedure under which the amount paid by a covered individual for a covered prescription drug purchased outside of the health plan will offset the covered individual's deductible. Requires an insurer, when removing a prescription drug from the insurer's formulary or changing the cost sharing requirements applying to the prescription drug, to give an insured for whom the drug has been prescribed 60 days notice of the insurer's action and provide an appeal process through which the insured may request an extension of coverage for the drug through the end of the insured's plan year.
Bill status signed all 5 stages cleared
Introduction
Mar 2020
Committee Review
Mar 2020
House Passage
Jan 2020
Senate Passage
Mar 2020
Signed into Law
Mar 2020
Introduced Mar 4, 2020 Signed Mar 18, 2020
Floor votes · Senate Mar 3, 2020 · House Jan 28, 2020

How they voted

401
Passed
Total votes 41
Mar 3, 2020
D Democratic8
8 Yea
100% Yea
R Republican33
32 Yea 1 Nay
96% Yea
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
39
Key actions
8
Committee
6
Amendments
5
Mar 18, 2020
Signed into law
Signed by the Governor
executive
Mar 11, 2020
Lower · Passed
Rules Suspended. Conference Committee Report 1: adopted by the House; Roll Call 398: yeas 91, nays 0
lower
Mar 11, 2020
Upper · Passed
Rules Suspended. Conference Committee Report 1: adopted by the Senate; Roll Call 399: yeas 47, nays 2
upper
Mar 11, 2020
Introduced
CCR # 1 filed in the Senate
upper
Mar 11, 2020
Introduced
CCR # 1 filed in the House
lower
Mar 4, 2020
Amended
House dissented from Senate amendments
lower
Mar 4, 2020
Introduced
Motion to dissent filed
lower
Mar 4, 2020
Amended
Returned to the House with amendments
upper
Mar 3, 2020
Senate · Passed
Senate Vote: pass (40-1)
senate
Mar 2, 2020
Amended
Amendment #2 (Ford J.D.) failed; Roll Call 265: yeas 13, nays 36
upper
Mar 2, 2020
Amended
Amendment #1 (Ford J.D.) failed; Roll Call 264: yeas 10, nays 38
upper
Mar 2, 2020
Upper · Passed
Amendment #3 (Bohacek) prevailed; voice vote
upper
Feb 27, 2020
Upper · Passed
Committee report: amend do pass, adopted
upper
Feb 13, 2020
Committee
Pursuant to Senate Rule 68(b); reassigned to Committee on Insurance and Financial Institutions
upper
Jan 29, 2020
Committee
Referred to the Senate
lower
Jan 28, 2020
House · Passed
House Vote: pass (91-0-1)
house
Jan 23, 2020
Lower · Passed
Committee report: amend do pass, adopted
lower
4 primary · 4 co-sponsors

Sponsors